title: Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease.
authors.affiliation: Department of Neuroscience, AMGEN Inc., Thousand Oaks, California 91320, USA. darcatz@aol.com
authors.forename: P A
authors.initials: PA
authors.lastname: Lapchak
authors.forename: D M
authors.initials: DM
authors.lastname: Gash
authors.forename: F
authors.initials: F
authors.lastname: Collins
authors.forename: D
authors.initials: D
authors.lastname: Hilt
authors.forename: P J
authors.initials: PJ
authors.lastname: Miller
authors.forename: D M
authors.initials: DM
authors.lastname: Araujo
mesh_terms: D000818:Animals; D002460:Cell Line; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins / Q000627:therapeutic use*; D009457:Neuroglia / Q000737:chemistry / Q000166:cytology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D018696:Neuroprotective Agents